ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association-Reference-Cited by-同舟云学术

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association

Published:2005-06 Issue:16_suppl Volume:23 Page:7013-7013
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Douillard J.-Y.¹,Rosell R.¹,Delena M.¹,Legroumellec A.¹,Torres A.¹,Carpagnano F.¹

Affiliation:

1. Ctr R Gauducheau, Saint Herblain, France; Hosp Univ Germans Trias i Pujol, Badalona, Spain; IRCCS Oncologico, Bari, Italy; Ctr Hospitalier P. Chubert, Vannes, France; Hosp clinico San-Carlos, Madrid, Spain; Osp San Paolo, Bari, Italy

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.7013

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Early-Stage (Stage I and II) Non-Small Cell Lung Cancer;Respiratory Medicine;2023

2. Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer;Current Opinion in Oncology;2015-03

3. Effect of HER2-Neu expression in primary tumor on the efficacy of adjuvant polychemotherapy in patients with stage i-ii small cell lung cancer;Russian Journal of Oncology;2013-06-15

4. Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer;Journal of Thoracic Oncology;2011-01

5. Cooperative Group Research Efforts in Thoracic Malignancies 2009: A Review From the 10th Annual International Lung Cancer Congress;Clinical Cancer Reviews;2009-12-01